The United States Generic Drugs Market is poised for substantial growth, with projections indicating an increase from $92.66 billion in 2023 to $127.41 billion by 2032, representing a compound annual growth rate (CAGR) of 3.60% during the forecast period. Several key factors drive this growth trajectory, including the increasing prevalence of chronic diseases, significant cost savings, and the availability of patent cliffs.
United States Generic Drugs Market Table of Content and Sample Download: https://www.renub.com/united-states-generic-drugs-market-p.php
United States Generic Drugs Market Size, Growth, Forecast 2024-2032